Cell Therapeutics, Inc. (the "Company")
CTIC announced today the results from its Annual Meeting of
Shareholders (the "Annual Meeting") held on Friday, August 31, 2012.
At the Annual Meeting, shareholders elected Richard L. Love, Mary O.
Mundinger, DrPH, and Jack W. Singer, M.D. to serve on the Company's Board of
Directors until the Company's 2015 Annual Meeting. Shareholders approved an
amendment to the Company's amended and restated articles of incorporation to
increase the total number of authorized shares and authorized shares of common
stock and approved an amendment to the Company's 2007 Equity Incentive Plan,
as amended and restated (the "Plan"), to increase the number of shares
available for issuance under the Plan.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in